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Microangiographic evaluation of the effects of heparin on pro-
gressive Masugi nephritis. Unilateral progressive Masugi nephritis
was produced in rabbits and studied by microangiography as well
as light and immunofluorescence microscopy. The following five
groups were studied: Group 1. Heparin was started simultane-
ously with nephrotoxic serum (NTS) and was given for one week.
The animals were then sacrificed along with the untreated con-
trols. Group 2. This was the same protocol as in group 1 but with
three weeks' heparin. Group 3. Heparin was started one day after
NTS and was given for three weeks. Group 4. Heparin was started
one to two weeks after NTS and was given for three weeks. Group
5: late effect group. Heparin was started simultaneously with NTS,
was given for four weeks, and the animals then were sacrificed 10
to 13 weeks later. Heparin dose was 5,000 U, s.c., per day in all
treated groups. The number of glomeruli seen per unit of cortex by
microangiography was significantly increased in the first through
the third groups, as compared to the controts. Group 1 did not
show this increase but there was some decrease of immunofluores-
cent fibrinogen. The late effect group (group 5) showed no modifi-
cation by the treatment, suggesting that an initial improvement
may have been negated by persistent immunologic insults after
heparin withdrawal.
Evaluation microangiographique des effets de l'hEparine sur Ia
néphrite progressive de Masugi. Une néphrite unilaterale de Masu-
gi a ete produite chez des lapins et etudiee par microangiographie
et par microscopie photonique et immunofiuorescence. Les cinq
groupes suivants ont eta etudies: 1) groupe simultane une semaine,
l'heparine est commencée en meme temps que le serum nephro-
toxique (NTS) et administree pendant une semaine, 2) groupe
simultane trois semaines, semblable a groupe 1, mais
l'administration d'heparine dure trois semaines, 3) groupe unjour,
l'heparine est commencee un jour apres NTS, et administrée
pendant trois semaines, 4) groupe une semaine, l'heparine est
commencée une a deux semaines après NTS et administree pen-
dant trois semaines, 5) groupe des effets tardils, l'heparine est
commencee en meme temps que NTS, donnee pendant 4 se-
maines, les animaux sont sacrifies 10 a 13 semaines plus tard. La
dose d'heparine est de 5,000 U, s.c., parjour dans tousles groupes
traités. Le nombre de glomerules vus par unite de cortex en
microangiographie est significativement augmenté dans le premier
et le troisieme groupe par comparaison avec les contrôles. Le
groupe une semaine n'a pas une telle augmentation, mais on
observe une diminution de Ia fluorescence du fibrinogene. Le
groupe des effets tardifs n'est pas modifle par le traitement, ce qui
suggère que l'amelioration initiale peut avoir été effacee par Ia
persistance du processus immunologique aprés l'arret de
l'hepathne.
The beneficial effects of anticoagulants in human
as well as experimental glomerulonephritis have
been reported [1-4], and it has been suggested that
intraglomerular coagulation plays an important role
in the progression of various glomerular lesions.
However, two recent reports by Bone et al [5] and
Border, Wilson, and Dixon [6] have questioned the
effects of anticoagulants in experimental glomerulo-
nephritis. There is a need for more basic information
on mechanisms and possible limitations of anticoagu-
lants before accepting them as an established
treatment.
In the present study, we quantitatively evaluated
both the prophylactic and therapeutic effects of
heparin in unilateral progressive Masugi nephritis, by
the use of microangiography as well as light and
immunofluorescent microscopy.
Methods
Experimental model. Albino rabbits weighing 2.0
to 2.5 kg were used. Unilateral progressive Masugi
nephritis was produced according to the method of
Sarre and Wirtz [7] and modified by Nagasawa [8],
which has been described in a previous report [9].
Briefly, after ligation of the right renal artery with
fine silk, duck anti-rabbit kidney serum (nephrotoxic
serum or NTS) was injected into the ear vein (2.5 ml!
kg of body wt). Twenty minutes later, the ligature
was released. In this experimental model, the non-
ligated kidney is known to progress to a contracted
kidney over a period of three or more months. We
were able to confirm this phenomenon (Fig. 1).
Experimental groups: Group 1 (simultaneous
NTS +H — one week group). Simultaneously with the
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Fig. 1. Experimental model: The non-ligated kidney progressed to
a contracted kidney, while the ligated kidney became
hypertrophic.
NTS injection, 500 U of heparin (H) was infused into
the opposite ear vein, and 2,000 U of heparin was
administered s.c. around the hip. Then, 2,500 U of
heparin was given s.c. every 12 hr (5,000 U per day).
In this group, heparin was continued for one week,
and then the animals were sacrificed. This heparin
dose was the same in all treated groups. In a pilot
study, clotting time, by the Lee-White method, in 12
normal rabbits given this heparin dose was prolonged
to about twice the normal value at one hour before
the scheduled administration of heparin.
Group 2 (simultaneous NTS +H — three weeks
group). Heparin was started simultaneously with
NTS, as above, and was continued for three weeks.
The animals then were sacrificed.
Group 3 (one day group). Heparin was started one
day after NTS administration, and was continued for
three weeks, as above.
Group 4 (one week group). Heparin was started
one (nine rabbits) to two weeks (seven rabbits) after
NTS, and was continued for three weeks, as above.
Group 5 (late-effect group). Heparin was started
simultaneously with NTS and was continued for four
weeks. Thereafter, the rabbits were kept for 10 to 13
weeks after heparin withdrawal, and then were
sacrificed.
Groups 1 and 5 had untreated controls with
matched surviving periods. The 2nd through 4th
groups shared an untreated control group, which was
sacrificed three (four rabbits) to five (four rabbits)
weeks after NTS. The first two groups were designed
to examine the early prophylactic effects of heparin,
the third and fourth groups for the therapeutic ef-
fects, thus simulating human situations, and the last
group for late, or remote effects of prophylactic
heparin.
Evaluation of glomerular lesions. After heparini-
zation to prevent thrombus formation, all animals
were sacrificed by exsanguination from the femoral
artery while under anesthesia. A catheter was insert-
ed into the left main renal artery via its aortic orifice,
and one of the first branches of the main renal artery
was tightly ligated. A small amount of normal saline
was gently infused through the catheter in order to
demarcate the area supplied by the ligated branch. In
the middle of the demarcated area, a thin slice of the
cortex (about 10 x 5 >< 1 mm) was obtained. This
cortical piece was divided for light, immunofluores-
cence, and electron microscopy (not included in this
report). The remaining kidney was processed for
microangiography.
Tissue for light microscopy was fixed in 10% neu-
tral buffered formalin, embedded in paraffin, and
sectioned 2- to 3- thick. The sections were stained
with hematoxylin and eosin (H&E) and periodic acid
Schiff (PAS). One hundred glomeruli were counted
each time and evaluated without any knowledge of
whether the case was treated or untreated. At one
week after NTS injection, microthrombi of fibrin and
fibrinoid material in the glomerular tuft were evaluat-
ed; at three to five weeks after NTS, crescent forma-
tion, and at a later stage, glomerular sclerosis were
evaluated, respectively.
Another tissue sample for immunofluorescence
microscopy was frozen at —70°C in N-hexane, pre-
cooled in dry ice and acetone bath, and was cut at 4-
to 5-,'i thick in cryostat at —20°C. The sections were
stained with fluorescein-isothiocyanate-labeled
(FITC) goat anti-rabbit y-globulin serum (Behring-
werke, West Germany) and FITC-guinea pig anti-
rabbit fibrinogen serum. The intensity of immunoflu-
ore scence was graded as —, or + +. Rabbit
fibrinogen was isolated by Laki's method [10]. Anti-
rabbit fibrinogen antibody was raised in guinea pigs,
with which FITC was conjugated according to the
method of Kawamura [11]. The FITC-labeled anti-
fIbrinogen serum was made monospecific by appro-
priate absorption procedures and had an F/P ratio of
1.27.
The processing of microangiography of the kidney
was almost the same as described previously [9],
according to the method of Ljungqvist [12]. After
irrigating the kidney with enough normal saline to
wash out the blood, a 7.5% aqueous suspension of
fine-grain barium sulfate (Micropaque) was perfused
at a hydrostatic pressure of 100cm of water, then at a
pressure of 180 cm of water for 90 mm at room
temperature. The kidney was fixed for at least 96 hr
in 10% neutral buffered formalin and was cut along
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its short axis at 750 is in thickness with a freezing
microtome. Angiography was performed at 28 KV
and 20 mA on a fine grain photographic emulsion
(Fuji FG-15), using a fine focus X-ray machine. The
exposure time was 4 mm. The microangiogram thus
produced was enlarged three times in size on Neo-
Pan film (Fuji), using Macro-Apparatus (multiphoto,
Nippon opticals). Then, this film was further
enlarged 4.5 times to be printed on a photograph, in
which the number of glomeruli depicted was calcu-
lated over a measured area of the cortex extending
from the capsule of the kidney to deep medulla. This
area of the cortex was 6.0 x 6.0 mm in original size.
One microangiogram in which the radioactive
opaque dye distributed evenly from the cortex to
medulla was examined in each case in the same
manner as the light microscopic section.
Statistical analysis was performed by the t test,
and the data were expressed as mean SEM.
Results
Mortality rate. The death rate before the time of
sacrifice is shown in Table 1. There was no signifi-
cant difference between the treated and control
groups. The dead animals were excluded from the
present study.
Early prophylactic effects of heparin. Group 1
(simultaneous NTS + H — one week group) and its
control, which were sacrificed one week after NTS
injection, represented early autologous phase of Ma-
sugi nephritis, judged from the presence of rabbit y-
globulin deposited in a linear fashion along glomeru-
lar basement membrane (GBM). The most promi-
nent glomerular change was deposition of fibrin-fibri-
noid materials in the capillary lumen and
occasionally in Bowman's space, i.e., exudative le-
sions. Although we could not see any significant
difference in the incidence of exudative lesions in the
treated and control groups by light microscopy, mi-
croangiographic examination revealed a definite in-
Groupsa
No. of
animals
No. of
deaths
1) Simultaneous NTS+H — one week 9 1 (11%)
Control 5 0 (0)
2) Simultaneous NTS+H — three weeks 20 5 (25)
3) One day group 11 3 (27)
4) One week group 22 6 (27)
Control 10 2 (20)
5) Late effect group 20 4 (20)
Control 23 4 (17)
a See Method's section for a description of the groups.
crease in numbers of the glomeruli visualized in the
heparin-treated group as compared to the control (P
<0.01) (Table 2, Figs. 2 and 3).
Intrarenal blood vessels appeared to be relatively
well-preserved, even in the controls at this stage of
the disease.
In group 2 (simultaneous NTS + H — three weeks
group) and its control, the pervasive glomerular
change was cellular crescent formation. In the group
treated with heparin for three weeks, there was a
significant decrease in crescent formation and an
increase in the glomeruli visualized on microangiog-
raphy (P < 0.01, respectively) as seen in Table 2 and
Figure 4. Figure 5 shows examples of both the
treated and control groups. In the controls who had
survived for three to five weeks after NTS infusion,
poor visualization of the smaller vessels as well as
the glomeruli was quite marked. On the other hand,
the treated group preserved its intrarenal blood sup-
ply, as judged from the microangiographs.
Therapeutic effects of heparin. The findings in
group 3 (one day group) and group 4 (one week
group) are shown in Table 2 and Figure 6, together
with those in group 2 (simultaneous NTS + H —
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Fig. 2. Group I (simultaneous NTS + H — one week group) and its
control: Light microscopic and microangiographic findings. Open
bars represent the control group; dotted bars, the heparin group;
and — , the mean SEM,
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Table 2. Light microscopic and microangiographic findings in all experimental groups
No. of
Glomerularchangcs, per 100 gloineruli"
No. of
Microanographic
findings5Exudative Crescent
Groups animals lesion formation Hyalinization animals no. of glorneruli
1) Simultaneous NTS+H—one week 8 35.5 9.8 — 7 81.9 8.1°
Control 5 49.6 2.2 — 5 29.8 2.4
2) Simultaneous NTS+H—threc weeks 15 — 20.7 7.2° — 14 83.1 7.5°
3) One day group 8 — 24.8 10.1" —. 6 53.2 l2.0
4) One week group 16 — 63.5 7.9 —- 13 38.1 3.1
Control 8 — 63.8 8.6 — 7 27.6 5.7
5) Late effect group 16 — 57.1 9.8 16 50.3 6.2
Control 19 — 36.6 8.9 6 66.3 8.5
See Method's section for description of groups.
"Values represent the mean SEM.
P <0.01 vs. control.
d P <0.05 vs. control.
three weeks group). The one day group (group 3), in
which heparin was started in the early heterologous
phase of Masugi nephritis, behaved like group 2
(simultaneous NTS + H — three weeks group). Al-
though the glomerular filling rate seen by microan-
giography was a little less than in the latter, it was
significant enough to be separated from the control
(P < 0.05).
Group 4 (one week group), in which heparin was
begun in the autologous phase with established gb-
memlar changes, however, showed no histological
improvement with treatment. Immunofluorescent
staining for fibrinogen in the gbomeruli became nega-
tive or very faint (±) in about 40% of the treated
group, while the control group showed moderate (+)
Fig. 3 A. Group I (simultaneous NTS + H — one week group). An abundant filling of the glonieruli is seen, in a degree comparable to the
normal which was shown in the previous report [9]. B. The control group, in contrast to A, there was a marked decrease of visualized
glomeruli, but with relatively preserved intrarenal vessels. (Magnification, x 25.)
Heparin in progressive Masugi nephritis 301
=
0
E
a
0)00
a0
E
0
a00
0
to heavy (+ +) staining (Fig. 7). There was no essen-
tial difference in histological and immunofluorescent
findings between the control rabbits sacrificed three
and five weeks after NTS infusion.
Late effect of prophylactic heparin. Data on the
late effect group (group 5) and its control are pre-
sented in Table 2 and Figure 8. In contrast to groups
1 and 2 (simultaneous NTH+H — one and three
weeks groups), the late effect group (group 5) who
survived 10 to 13 weeks after cessation of heparin
showed increased hyalinization and poor filling of the
glomeruli with markedly tortuous intrarenal vessels
(Fig. 9). There was no statistically significant differ-
ence, however, between the treated and control
groups. Immunohistological findings in the treated
group were also consistent with the failure of heparin
treatment. Except for the completely hyalinized gb-
meruli, the remaining glomeruli still retained the y-
globulin in a linear fashion along the capillary wall
(Fig. 10) and also a considerable amount of fibrino-
gen-reactive materials deposited in the glomerular
tuft (Fig. 11) to the same degree as in the controls.
Discussion
Following the pioneer work on the protective ef-
fect of heparin in experimental glomerulonephritis by
Silfverskjöld [1311 and Kleinerman [141, Vissalli et al
[1, 15] have clearly demonstrated that intravascular
or intraglomerular coagulation plays an important
role in the pathogenesis of glomerular lesions. Gb-
merular lesions resulting from intravascular coagula-
tion cover the whole range of morphological reac-
tions seen in glomerulonephritis, except for that of
epimembranous glomerulonephritis [15, 161. On the
basis of these experimental studies, anticoagulant
therapy has been applied to human cases with some
beneficial effects [4].
The present results of early prophylactic effects of
heparin are consistent with those of Halpern et a! [2]
and Borrero et al [3], in addition to the investigations
cited above [1, 13, 14]. Our report, however, adds
the following two points: the first is that anticoagu-
lant effects were evaluated by microangiography.
The beneficial effects of early prophylactic heparin
were well-correlated with a better blood supply to
the small vessels and glomeruli in the renal cortex.
Especially in group 1 (the simultaneous NTS + H—
one week group), the microangiographs showed the
heparin effect more clearly than the routine histolog-
ic study. Thus, one of the mechanisms of heparin is
probably to prevent microthrombus formation and
thus protect the renal cortex from ischemia.
Ljungqvist, Sallström, and Biberfeld [17] observed
that when the gbomerular lesion in Masugi nephritis
is sufficiently severe and extensive, the intrarenal
vasculature seen by microangiography resulted in
alterations implying a relative cortical ischemia. Fur-
thermore, the present result is supported by the
experiments of Naish et al [18], who used the defibri-
nating agent ancrod, which suggested that the pro-
tective effect of anticoagulants was related to a
reduction in glomerular fibrin deposition.
The second point to be mentioned is that the pres-
ent study used progressive and severe Masugi
nephritis as an experimental model. Conventional
Masugi nephritis produced by one shot infusion of
NTS into animals with two intact kidneys is usually
mild and has a tendency to spontaneous healing [1]
For example, in a series by Borrero et al [3], who
used the conventional Masugi nephritis, the untreat-
ed control showed crescent formation in 34% (mean)
of the glomeruli examined, whereas it was 63.8
8.6% in our studies.
Recently, Bone et al [51 and Border, Wilson, and
Dixon [6] have reported that they were unable to
obtain any beneficial heparin effects on experimental
glomerulonephritis, supporting the previous report
by Briggs, Kwaan, and Potter [19]. Thomson, Simp-
son, and Peters [201! have pointed out that a heparin
dose of 2,000 U/kg/day was required before there
was significant reduction in fibrin deposition and
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Fig. 4. Group 2 (simultaneous NTS + H — three weeks group) and
its control. Open bars represent the control group; dotted bars,
the hepann group; and —t , the mean SEM.
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Fig. 5 A. Group 2 (simultaneous NTS + H—3 weeks group). Ample glomerular filling rate was maintained, though visualization of the
superficial glomeruli in the cortex was slightly less than in Figure 3A. B. The Control group. Scanty filling of the glomeruli and damaged
intrarenal vessel system are seen. (Magnification, x 25.)
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Fig. 6. Results ofgroup 3 (one day group) and group 4 (one week
group) in a comparison with group 2 (simultaneous NTS + H—
three weeks group). Open bars represent the control group; dotted
bars, the heparin group; and i—i, the mean 5EM.
extracapillary cell proliferation. But, heparin dos-
ages in these three reports as well as in the present
study were more than that. In the studies by Bone et
al [5], 57% of the untreated rats with progressive
anti-GBM nephritis, produced by the serial adminis-
tration of heterologous antiserum in two stages, had
epithelial crescents in most glomeruli. Although Bor-
der et al [6] have examined heparin effects on both
immune complex and anti-GBM glomerulonephritis,
only the latter will be discussed here. According to
their description, the immediate type of anti-GBM
glomerulonephritis ran a progressive course leading
to death within seven to ten days, with virtually all of
the glomeruli involved by cellular proliferation,
necrosis, and crescent formation. The severity of
glomerular injuries in the report by Briggs et al was
not described clearly enough to be compared. The
glomerular injuries in those two reports by Bone et a!
15] and Border et al [6] appear to be equal to or
somewhat more severe than in our series, though an
exact comparison is difficult. It is, therefore, con-
ceivable that an extremely severe glomerular injury
may be beyond the reach of heparin effects and that
the lesser severity of glomerular lesions in the pres-
ent study may have been more amenable to modula-
tion by heparin.
Group 2 Group 4 Group 2 Group4
Control Group 3 Control Group 3
group group
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Fig. 8. Group 5 (late effect group) and its control. Open bars
represent the control group; dotted bars, the heparin group; and
(+) i—i , the mean SEM.
Grade of staining
Fig. 7. Immunofluorescent staining for fibrinogen-reactive mate-
rials deposited in the glomeruli. See Methods section for grading
scale.
A therapeutic trial of heparin, which was started
one to two weeks after NTS injection, yielded no
improvement as judged by both light microscopy and
microangiography. The immunofluorescent study,
however, disclosed negative or faint staining of fi-
brinogen-reactive materials in the glomeruli of occa-
sional treated cases. Borrero et al [31 have reported
almost the same experience. When they started War-
farm® 14 days after NTS injection, they could see no
reduction in crescent formation but some decrease of
fresh fibrinous exudate in the glomeruli as compared
to the control.
The late effects of prophylactic heparin are of
interest. As far as we know, no experimental study
has been performed in which the late or remote effect
of hepann was evaluated. We found no significant
modification by the treatment. It is likely that the
initial improvement attained by the early prophylac-
tic heparin regimen had disappeared after stopping
heparin. In individual glomeruli from the treated Fig. 9. A microangiograph from group 5 (late effect group). A
group, definite amounts of fibrinogen as well as y devastated cortical vessel system with marked tortuosity means
globulin were found along relatively well-preserved that it is approaching a contracted state. (Magnification, x 10.)
I
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Fig. 11. Lumpy deposits of fibrinogen-reactive materials by immanofluorescence in a rela-
tively preserved glomerulus, from (group 5) (late effect group). (Magnification, x600.)
capillary loops. Two immunological mechanisms,
i.e., circulating immune complexes and anti-GBM
antibody have been elucidated in the pathogenesis of
glomerulonephritis [21]. Since it is known that gb-
merular deposition of immune complexes and heter-
ologous anti-GBM antibody are not affected by anti-
coagulant treatment [1, 6], persistent immunologic
mechanisms appear to have provoked again the
coagulation processes after withdrawal of heparin
treatment. These results may represent a limitation
of anticoagulant therapy. We suggest that anticoagu-
lants may have to be reinforced by corticosteroid
hormone and/or immunosuppressive measures in
order to weaken the activity of immunologic mecha-
nisms associated with glomerulonephritis.
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